174 related articles for article (PubMed ID: 30556925)
41. Stereotyped subset #1 chronic lymphocytic leukemia: a direct link between B-cell receptor structure, function, and patients' prognosis.
Del Giudice I; Chiaretti S; Santangelo S; Tavolaro S; Peragine N; Marinelli M; Ilari C; Raponi S; Messina M; Nanni M; Mauro FR; Piciocchi A; Bontempi K; Rossi D; Gaidano G; Guarini A; Foà R
Am J Hematol; 2014 Jan; 89(1):74-82. PubMed ID: 24030933
[TBL] [Abstract][Full Text] [Related]
42. Novel role of prostate apoptosis response-4 tumor suppressor in B-cell chronic lymphocytic leukemia.
McKenna MK; Noothi SK; Alhakeem SS; Oben KZ; Greene JT; Mani R; Perry KL; Collard JP; Rivas JR; Hildebrandt GC; Fleischman RA; Durbin EB; Byrd JC; Wang C; Muthusamy N; Rangnekar VM; Bondada S
Blood; 2018 Jun; 131(26):2943-2954. PubMed ID: 29695515
[TBL] [Abstract][Full Text] [Related]
43. Chronic Lymphocytic Leukemia-Derived IL-10 Suppresses Antitumor Immunity.
Alhakeem SS; McKenna MK; Oben KZ; Noothi SK; Rivas JR; Hildebrandt GC; Fleischman RA; Rangnekar VM; Muthusamy N; Bondada S
J Immunol; 2018 Jun; 200(12):4180-4189. PubMed ID: 29712773
[TBL] [Abstract][Full Text] [Related]
44. Next-generation IgVH sequencing CLL-like monoclonal B-cell lymphocytosis reveals frequent oligoclonality and ongoing hypermutation.
Klinger M; Zheng J; Elenitoba-Johnson KS; Perkins SL; Faham M; Bahler DW
Leukemia; 2016 May; 30(5):1055-61. PubMed ID: 26686246
[TBL] [Abstract][Full Text] [Related]
45. The immunoglobulin genes and chronic lymphocytic leukemia (CLL).
Tobin G
Ups J Med Sci; 2005; 110(2):97-113. PubMed ID: 16075892
[TBL] [Abstract][Full Text] [Related]
46. Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia.
Papakonstantinou N; Ntoufa S; Tsagiopoulou M; Moysiadis T; Bhoi S; Malousi A; Psomopoulos F; Mansouri L; Laidou S; Papazoglou D; Gounari M; Pasentsis K; Plevova K; Kuci-Emruli V; Duran-Ferrer M; Davis Z; Ek S; Rossi D; Gaidano G; Ritgen M; Oscier D; Stavroyianni N; Pospisilova S; Davi F; Ghia P; Hadzidimitriou A; Belessi C; Martin-Subero JI; Pott C; Rosenquist R; Stamatopoulos K
Int J Cancer; 2019 Jun; 144(11):2695-2706. PubMed ID: 30447004
[TBL] [Abstract][Full Text] [Related]
47. Molecular evidence for EBV and CMV persistence in a subset of patients with chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors.
Kostareli E; Hadzidimitriou A; Stavroyianni N; Darzentas N; Athanasiadou A; Gounari M; Bikos V; Agathagelidis A; Touloumenidou T; Zorbas I; Kouvatsi A; Laoutaris N; Fassas A; Anagnostopoulos A; Belessi C; Stamatopoulos K
Leukemia; 2009 May; 23(5):919-24. PubMed ID: 19148139
[TBL] [Abstract][Full Text] [Related]
48. CD5 promotes IL-10 production in chronic lymphocytic leukemia B cells through STAT3 and NFAT2 activation.
Garaud S; Morva A; Lemoine S; Hillion S; Bordron A; Pers JO; Berthou C; Mageed RA; Renaudineau Y; Youinou P
J Immunol; 2011 Apr; 186(8):4835-44. PubMed ID: 21398617
[TBL] [Abstract][Full Text] [Related]
49. The inhibitory receptor Siglec-G controls the severity of chronic lymphocytic leukemia.
Röder B; Fahnenstiel H; Schäfer S; Budeus B; Dampmann M; Eichhorn M; Angermüller S; Brost C; Winkler TH; Seifert M; Nitschke L
EMBO Rep; 2023 Aug; 24(8):e56420. PubMed ID: 37424400
[TBL] [Abstract][Full Text] [Related]
50. CXCR4 hyperactivation cooperates with TCL1 in CLL development and aggressiveness.
Lewis R; Maurer HC; Singh N; Gonzalez-Menendez I; Wirth M; Schick M; Zhang L; Isaakidis K; Scherger AK; Schulze V; Lu J; Zenz T; Steiger K; Rad R; Quintanilla-Martinez L; Espeli M; Balabanian K; Keller U; Habringer S
Leukemia; 2021 Oct; 35(10):2895-2905. PubMed ID: 34363012
[TBL] [Abstract][Full Text] [Related]
51. Distinct clonal origin in two cases of Hodgkin's lymphoma variant of Richter's syndrome associated With EBV infection.
de Leval L; Vivario M; De Prijck B; Zhou Y; Boniver J; Harris NL; Isaacson P; Du MQ
Am J Surg Pathol; 2004 May; 28(5):679-86. PubMed ID: 15105659
[TBL] [Abstract][Full Text] [Related]
52. A systematic approach for peptide characterization of B-cell receptor in chronic lymphocytic leukemia cells.
Díez P; Ibarrola N; Dégano RM; Lécrevisse Q; Rodriguez-Caballero A; Criado I; Nieto WG; Góngora R; González M; Almeida J; Orfao A; Fuentes M
Oncotarget; 2017 Jun; 8(26):42836-42846. PubMed ID: 28467808
[TBL] [Abstract][Full Text] [Related]
53. The Eμ enhancer region influences H chain expression and B cell fate without impacting IgVH repertoire and immune response in vivo.
Marquet M; Garot A; Bender S; Carrion C; Rouaud P; Lecardeur S; Denizot Y; Cogné M; Pinaud E
J Immunol; 2014 Aug; 193(3):1171-83. PubMed ID: 24965776
[TBL] [Abstract][Full Text] [Related]
54. Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study.
Bomben R; Dal Bo M; Capello D; Forconi F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Zucchetto A; Bertoni F; Rossi FM; Bulian P; Cattarossi I; Ilariucci F; Sozzi E; Spina V; Zucca E; Degan M; Lauria F; Del Poeta G; Efremov DG; Marasca R; Gaidano G; Gattei V
Br J Haematol; 2009 Feb; 144(4):492-506. PubMed ID: 19036101
[TBL] [Abstract][Full Text] [Related]
55. [Expression of stereotyped B-cell receptor and its clinical value in chronic lymphocytic leukemia].
Yu Z; Li ZJ; Yi SH; Zhou KS; Hao M; Li CH; Qi JY; Qiu LG
Zhonghua Yi Xue Za Zhi; 2011 Dec; 91(46):3267-70. PubMed ID: 22333147
[TBL] [Abstract][Full Text] [Related]
56. Evidence for distinct pathomechanisms in genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, and apoptosis-associated genes.
Kienle DL; Korz C; Hosch B; Benner A; Mertens D; Habermann A; Kröber A; Jäger U; Lichter P; Döhner H; Stilgenbauer S
J Clin Oncol; 2005 Jun; 23(16):3780-92. PubMed ID: 15867199
[TBL] [Abstract][Full Text] [Related]
57. Absence of caveolin-1 leads to delayed development of chronic lymphocytic leukemia in Eμ-TCL1 mouse model.
Shukla A; Cutucache CE; Sutton GL; Pitner MA; Rai K; Rai S; Opavsky R; Swanson PC; Joshi SS
Exp Hematol; 2016 Jan; 44(1):30-7.e1. PubMed ID: 26435347
[TBL] [Abstract][Full Text] [Related]
58. What do somatic hypermutation and class switch recombination teach us about chronic lymphocytic leukaemia pathogenesis?
Oppezzo P; Dighiero G
Curr Top Microbiol Immunol; 2005; 294():71-89. PubMed ID: 16323428
[TBL] [Abstract][Full Text] [Related]
59. The NZB mouse as a model for chronic lymphocytic leukemia.
Phillips JA; Mehta K; Fernandez C; Raveché ES
Cancer Res; 1992 Jan; 52(2):437-43. PubMed ID: 1370214
[TBL] [Abstract][Full Text] [Related]
60. Immunoglobulin heavy chain variable gene usage and (super)-antigen drive in chronic lymphocytic leukemia.
Bühler A; Zenz T; Stilgenbauer S
Clin Cancer Res; 2010 Jan; 16(2):373-5. PubMed ID: 20068107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
